Even though drug company Mylan agreed to pay $465 million to quickly settle a Justice Department investigation into allegations that it deliberately overcharged Medicaid for its EpiPen emergency allergy injector, a new report from the Department of Health and Human Services indicates that taxpayers may have overpaid more than twice that amount over ten years. [More]
